Hela Romdhani
Education
Ph.D., mathematics and statistics, Laval University; M.S., information processing, National Engineering School of Tunis; B.S., statistics and data analysis, Higher School of Statistics and Data Analysis; Diploma, mathematics and computer sciences, Higher School Preparatory Classes
Summary of Experience
Dr. Romdhani specializes in the application of advanced statistical methods to address a wide array of research questions in health care, including in the area of health economics and outcomes research (HEOR). She has broad quantitative research experience conducting studies to assess the economic burden of various illnesses, treatment patterns, and drug safety and efficacy profiles in a range of therapeutic areas, including oncology, gastroenterology, immunology, neurology, cardiology, infectious diseases, and rare and hereditary diseases. Dr. Romdhani’s expertise includes conducting real-world evidence (RWE) studies, retrospective database analyses, chart review studies, and systematic and targeted literature reviews. Her research has been published in peer-reviewed journals and presented at clinical and economic research conferences.
- 
                                                        Real-world clinical outcomes and healthcare costs in patients with Crohn's disease treated with vedolizumab versus ustekinumab in the United StatesCurrent Medical Research and Opinion, 2024 
 2024Chiorean M, Jiang J, Candela N, Chen G, Romdhani H, Latremouille-Viau D, Shi S, Bungay R, Guerin A, Fan T 
- 
                                                        Real-World Experience of Pediatric Patients Treated with Peanut (Arachis Hypogaea) Allergen Powder-DnfpAnnals of Allergy, Asthma & Immunology, 2023 
 2023Portnoy J, Shroba J, Tilles S, Romdhani H, Donelson SM, Latremouille-Viau D, Bungay R, Chen K, McCann W 
- 
                                                        Disease Burden, Treatment Patterns, and Economic Impact of Rectovaginal Fistulas in Patients with Crohn's Disease: Findings from a Retrospective, Observational, Longitudinal Study Based on US Claims DatabasesPharmacoEconomics - Open, 2023 
 2023Karki C, Latremouille-Viau D, Gilaberte I, Hantsbarger G, Romdhani H, Lightner AL 
- 
                                                        Treatment and Comorbidity Burden among People Living with HIV: A Review of Systematic Literature ReviewsJournal of Drug Assessment, 2022 
 2022Taiwo BO, Romdhani H, Lafeuille MH, Bhojwani R, Milbers K, Donga P 
- 
                                                        Real-World Utilization and Safety of Daratumumab IV Rapid Infusions Administered in a Community Setting: A Retrospective Observational StudyDrugs - Real World Outcomes, 2021 
 2021Gordan L, Chang M, Lafeuille MH, Romdhani H, Paramasivam F, Maiese EM, McKay C 
- 
                                                        Disease Management and Outcomes in Patients Hospitalized for Acute Heart Failure in JapanCardiology and Therapy, 2021 
 2021Chen L, Ionescu-Ittu R, Romdhani H, Guérin A, Kessler P, Borentain M, Friend K, DeSouza M, Sato N 
- 
                                                        Management of Patients with Metastatic Castration-Sensitive Prostate Cancer in the Real-World Setting in the United StatesThe Journal of Urology, 2021 
 2021Ryan CJ, Ke X, Lafeuille MH, Romdhani H, Kinkead F, Lefebvre P, Petrilla A, Pulungan Z, Kim S, D'Andrea DM, Francis P, Freedland SJ 
- 
                                                        Identification of patients with metastatic castration-sensitive or metastatic castration-resistant prostate cancer using administrative health claims and laboratory dataCurrent Medical Research and Opinion, 2021 
 2021Freedland SJ, Ke X, Lafeuille MH, Romdhani H, Kinkead F, Lefebvre P, Petrilla A, Pulungan Z, Kim S, D'Andrea DM, Francis P, Ryan CJ 
- 
                                                        Adherence, Healthcare Resource Utilization, and Costs in Medicaid Beneficiaries with Schizophrenia Transitioning from Once-Monthly to Once-Every-3-Months Paliperidone PalmitatePharmacoEconomics - Open, 2019 
 2019Emond B, Joshi K, El Khoury AC, Lafeuille MH, Pilon D, Tandon N, Romdhani H, Lefebvre P 
- 
                                                        Comparison of Time to Next Treatment, Health Care Resource Utilization, and Costs in Patients with Chronic Lymphocytic Leukemia Initiated on Front-line Ibrutinib or ChemoimmunotherapyClinical Lymphoma, Myeloma & Leukemia, 2019 
 2019Emond B, Sundaram M, Romdhani H, Lefebvre P, Wang S, Mato A 
- 
                                                        Long-Term Benefits of Rapid Antiretroviral Therapy Initiation in Reducing Medical and Overall Health Care Costs Among Medicaid-Covered Patients with Human Immunodeficiency VirusJournal of Managed Care & Specialty Pharmacy, 2019 
 2019Benson C, Emond B, Romdhani H, Lefebvre P, Côté-Sergent A, Shohoudi A, Tandon N, Chow W, Dunn K 
- 
                                                        Economic burden of treatment failure in chronic lymphocytic leukemia patientsCurrent Medical Research and Opinion. 2018 Jun;34(6):1135-1142 
 2018Wang S, Lafeuille MH, Lefebvre P, Romdhani H, Emond B, Senbetta M 
- 
                                                        Risk Factors, Health Care Resource Utilization, and Costs Associated with Nonadherence to Antiretrovirals in Medicaid-Insured Patients with HIVJournal of Managed Care & Specialty Pharmacy. 2018 Oct;24(10):1040-1051 
 2018Dunn K, Lafeuille MH, Jiao X, Romdhani H, Emond B, Woodruff K, Pesa J, Tandon N, Lefebvre P 
- 
                                                        Monitoring of Hematologic, Cardiac, and Hepatic Function in Post-Menopausal Women with HR+/HER2- Metastatic Breast CancerAdvances in Therapy. 2018 Aug;35(8):1251-1264 
 2018Guérin A, Goldschmidt D, Small T, Gagnon-Sanschagrin P, Romdhani H, Gauthier G, Kelkar S, Wu EQ, Niravath P, Dalal AA 
- 
                                                        Current Treatment Patterns Among Postmenopausal Women with HR+/HER2- Metastatic Breast Cancer in US Community Oncology Practices: An Observational StudyAdvances in Therapy. 26 Mar 2018:1-12 
 2018Goldschmidt D, Dalal AA, Romdhani H, Kelkar S, Guerin A, Gauthier G, Wu EQ, Niravath P, Small T 
